Ingevity Corporation — Earnings Quality Grade F
NGVT · Basic Materials
Major red flags
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 40 days, change -0 days YoY
AR growth -3.4% vs revenue growth -2.7%
Revenue -2.7%, CFFO 157.5%. Cash follows revenue
Expense Quality
Inventory -5.1% vs COGS -4.0%. Normal
CapEx growth -25.6% vs revenue -2.7%. Normal
SG&A/Gross Profit = 37.1%. Normal
Gross margin 39.5%, change +0.8pp. Stable
Cash Flow Quality
CFFO < Net Income for 3 consecutive years
FCF $0.3B, FCF/NI = -1.64
Accruals ratio = -30.2%. Low accruals
Cash $0.1B covers only 6% of debt $1.2B
Balance Sheet Health
Goodwill+Intangibles $0.2B = 740% of equity. Over 50%
Debt/EBITDA = 30.0x (>4x). Financial stress
Other assets 1.5% vs revenue -2.7%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions positive
Goodwill+Intangibles change -56% YoY. Normal
Manipulation Score
M-Score = -4.08 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor NGVT continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25